Article
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma.
American journal of hematology - 1 May 2016
Panero Julieta, Alves-Paiva Raquel M, Roisman Alejandro, Santana-Lemos Barbara A, Falcão Roberto P, Oliveira Gustavo, Martins Diego, Stanganelli Carmen, Slavutsky Irma, Calado Rodrigo T
Abstract excerpt
Mantle cell lymphoma (MCL) is an aggressive lymphoid neoplasm with poor prognosis. Acquired telomerase reverse transcriptase gene promoter (TERTp) mutations are among the most frequent somatic non-coding mutations in cancers. In this study, the prevalence of TERTp mutations in 24 MCL and 21 other lymphoid neoplasias (oLN) was investigated. Eight MCL samples (33%) carried TERTp mutations, two homozygous and six...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
